Sexual and Reproductive Problems Associated with Neurodegenerative Disorders: A Narrative Review

Document Type : Analytic Review

Authors
Department of Anatomical Sciences, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Abstract
Neurological disorders are illnesses in which the function of neurons in the brain and spinal cord is disrupted. In neurodegenerative diseases, based on various factors such as the etiology of the disease, the patient's age, and the brain and /or spinal cord region involved, the affected person may face a wide variety of signs and symptoms. In numerous neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS), according to the disease pathobiology, some sexual and reproductive problems, like sexual dysfunction, low sperm quality, and sterility, have been raised. Although sexual and fertility issues could result in several individual complications and heavy social burdens, limited studies have addressed these topics. This narrative review highlights sexual and reproductive disabilities in several neurological disorders, such as spinal cord injury (SCI) and MS.

Keywords

Subjects


1. Muñoz-de-la-Torre, L., et al., Follicular Development and Secretion of Ovarian Hormones during the Juvenile and Adult Reproductive Lives of the Myelin Mutant taiep Rat: An Animal Model of Demyelinating Diseases. International journal of endocrinology, 2018. 2018.
2. Feigin, V.L., et al., The global burden of neurological disorders: translating evidence into policy. The Lancet Neurology, 2020. 19(3): p. 255-265.
3. Calabrò, R.S., Sexual dysfunction in neurological disorders: do we see just the tip of the iceberg? Acta Bio Medica: Atenei Parmensis, 2018. 89(2): p. 274.
4. Wang, L., et al., Gonadotropin-releasing hormone receptor system: modulatory role in aging and neurodegeneration. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 2010. 9(5): p. 651-660.
5. Schauer, C., et al., Hypothalamic gonadotropin-releasing hormone (GnRH) receptor neurons fire in synchrony with the female reproductive cycle. Journal of neurophysiology, 2015. 114(2): p. 1008-1021.
6. Rosqvist, K., et al., Factors associated with health‐related quality of life in late‐stage Parkinson's disease. Movement Disorders Clinical Practice, 2021. 8(4): p. 563-570.
7. Bechoua, S., et al., Outcomes with intracytoplasmic sperm injection of cryopreserved sperm from men with spinal cord injury. Basic and Clinical Andrology, 2013. 23(1): p. 1-10.
8. Hess, M.J. and S. Hough, Impact of spinal cord injury on sexuality: broad-based clinical practice intervention and practical application. The journal of spinal cord medicine, 2012. 35(4): p. 211-218.
9. Alexander, M.S., et al., Measurement of Sexual Functioning After Spinal Cord Injury: Preferred Instruments: Report of the National Institute on Disability and Rehabilitation Research Spinal Cord Injury Measures Meeting. The journal of spinal cord medicine, 2009. 32(3): p. 226-236.
10. Trofimenko, V. and J.M. Hotaling, Fertility treatment in spinal cord injury and other neurologic disease. Translational Andrology and Urology, 2016. 5(1): p. 102.
11. Sinha, V., et al., Reproductive health of men with spinal cord injury. Topics in spinal cord injury rehabilitation, 2017. 23(1): p. 31-41.
12. da Silva, B.F., et al., Is sperm cryopreservation an option for fertility preservation in patients with spinal cord injury-induced anejaculation? Fertility and sterility, 2010. 94(2): p. 564-573.
13. Iremashvili, V., et al., Semen quality remains stable during the chronic phase of spinal cord injury: a longitudinal study. The Journal of urology, 2010. 184(5): p. 2073-2077.
14. Pavese, C. and T.M. Kessler, Prediction of Lower Urinary Tract, Sexual, and Bowel Function, and Autonomic Dysreflexia after Spinal Cord Injury. Biomedicines, 2023. 11(6): p. 1644.
15. Rutberg, L., B. Friden, and A. Karlsson, Amenorrhoea in newly spinal cord injured women: an effect of hyperprolactinaemia? Spinal Cord, 2008. 46(3): p. 189-191.
16. Breijyeh, Z. and R. Karaman, Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules, 2020. 25(24): p. 5789.
17. Mayeux, R. and Y. Stern, Epidemiology of Alzheimer disease. Cold Spring Harbor perspectives in medicine, 2012. 2(8): p. a006239.
18. Boutet, C., et al., Detection of volume loss in hippocampal layers in Alzheimer's disease using 7 T MRI: a feasibility study. NeuroImage: Clinical, 2014. 5: p. 341-348.
19. Rahman, M.M. and C. Lendel, Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology. Molecular Neurodegeneration, 2021. 16(1): p. 1-30.
20. Ando, K., et al., Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis. Frontiers in Molecular Neuroscience, 2021. 13: p. 583755.
21. Cheong, R.Y., S. Gabery, and Å. Petersén, The role of hypothalamic pathology for non-motor features of Huntington’s disease. Journal of Huntington's disease, 2019. 8(4): p. 375-391.
22. DeTure, M.A. and D.W. Dickson, The neuropathological diagnosis of Alzheimer’s disease. Molecular neurodegeneration, 2019. 14(1): p. 1-18.
23. Lysikova, E., et al., APPswe/PS1dE9/Blg Transgenic Mouse Line for Modeling Cerebral Amyloid Angiopathy Associated with Alzheimer’s Disease. Molecular Biology, 2023. 57(1): p. 74-82.
24. Udeh-Momoh, C. and T. Watermeyer, Female specific risk factors for the development of Alzheimer’s disease neuropathology and cognitive impairment: Call for a precision medicine approach. Ageing Research Reviews, 2021. 71: p. 101459.
25. Balestrino, R. and A. Schapira, Parkinson disease. European journal of neurology, 2020. 27(1): p. 27-42.
26. Cerri, S., L. Mus, and F. Blandini, Parkinson’s disease in women and men: what’s the difference? Journal of Parkinson's disease, 2019. 9(3): p. 501-515.
27. Poewe, W., Non‐motor symptoms in Parkinson’s disease. European journal of neurology, 2008. 15: p. 14-20.
28. De Luca, R., et al., Sexual Dysfunctions in Females with Parkinson’s Disease: A Cross-Sectional Study with a Psycho-Endocrinological Perspective. Medicina, 2023. 59(5): p. 845.
29. Tysnes, O.-B. and A. Storstein, Epidemiology of Parkinson’s disease. Journal of neural transmission, 2017. 124(8): p. 901-905.
30. Mamelak, M., Parkinson’s disease, the dopaminergic neuron and gammahydroxybutyrate. Neurology and Therapy, 2018. 7(1): p. 5-11.
31. Santa Rosa Malcher, C.M., et al., Sexual disorders and quality of life in Parkinson's disease. Sexual Medicine, 2021. 9(1): p. 100280-100280.
32. Raciti, L., et al., Sexual dysfunction in Parkinson disease: a multicenter Italian cross-sectional study on a still overlooked problem. The Journal of Sexual Medicine, 2020. 17(10): p. 1914-1925.
33. Benigno, M.d.S., C. Amaral Domingues, and M.A. Araujo Leite, Sexual Dysfunction in Parkinson’s disease: A systematic review of the arizona sexual experience scale sexual dysfunction in Parkinson disease: A systematic review of the arizona sexual experience scale. Journal of Geriatric Psychiatry and Neurology, 2023. 36(2): p. 87-97.
34. Sakakibara, R., et al., Sexual Problems in Parkinson’s Disease, in Psychiatry of Parkinson's Disease. 2012, Karger Publishers. p. 71-76.
35. Friedman, D., Sudden unexpected death in epilepsy. Current Opinion in Neurology, 2022. 35(2): p. 181-188.
36. Alimoradi, Z., M.D. Griffiths, and A.H. Pakpour, Epilepsy, sexual function, and mindfulness-based cognitive therapy, in Handbook of Cognitive Behavioral Therapy by Disorder. 2023, Elsevier. p. 135-146.
37. Atif, M., M.R. Sarwar, and S. Scahill, The relationship between epilepsy and sexual dysfunction: a review of the literature. Springerplus, 2016. 5(1): p. 1-10.
38. Yang, Y. and X. Wang, Sexual dysfunction related to antiepileptic drugs in patients with epilepsy. Expert opinion on drug safety, 2016. 15(1): p. 31-42.
39. Eklioglu, O.A. and S. Ilgin, Adverse effects of antiepileptic drugs on hormones of the hypothalamic-pituitary-gonadal axis in males: A review. Toxicology, 2022. 465: p. 153043.
40. Nopoulos, P.C., Huntington disease: a single-gene degenerative disorder of the striatum. Dialogues in clinical neuroscience, 2022.
41. Zielonka, D. and B. Stawinska-Witoszynska, Gender differences in non-sex linked disorders: insights from Huntington's disease. Frontiers in Neurology, 2020. 11: p. 571.
42. Eshmawey, M., Sexuality and neurodegenerative disease: an unmet challenge for patients, caregivers, and treatment. Neurodegenerative Diseases, 2021. 21(3-4): p. 63-73.
43. Reininghaus, E. and N. Lackner, Relationship satisfaction and sexuality in Huntington's disease. Handbook of clinical neurology, 2015. 130: p. 325-334.
44. Politis, M., et al., Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain, 2008. 131(11): p. 2860-2869.
45. Saleh, N., et al., Neuroendocrine disturbances in Huntington's disease. PloS one, 2009. 4(3): p. e4962.
46. Kalliolia, E., et al., A 24-hour study of the hypothalamo-pituitary axes in Huntington’s disease. PLoS One, 2015. 10(10): p. e0138848.
47. Markianos, M., et al., Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia. Annals of neurology, 2005. 57(4): p. 520-525.
48. Fahy, N., et al., Genetic risk for Huntington Disease and reproductive decision‐making: A systematic review. Clinical Genetics, 2023.
49. Sparaco, M. and S. Bonavita, The role of sex hormones in women with multiple sclerosis: From puberty to assisted reproductive techniques. Frontiers in Neuroendocrinology, 2021. 60: p. 100889.
50. Livingston, T., et al., Quantifying differences in health care consumption for the management of multiple sclerosis within privately and publicly insured health care programs. Journal of Managed Care & Specialty Pharmacy, 2016. 22(12): p. 1385-1391.
51. Gökçe, Ş.F., et al., Prevalence of multiple sclerosis in an urban population of Sivas province in Turkey. Turkish Journal of Medical Sciences, 2019. 49(1): p. 288-294.
52. Ghasemi, N., S. Razavi, and E. Nikzad, Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell Journal (Yakhteh), 2017. 19(1): p. 1.
53. Ysrraelit, M.C. and J. Correale, Impact of sex hormones on immune function and multiple sclerosis development. Immunology, 2019. 156(1): p. 9-22.
54. Guo, Z.-N., et al., Multiple sclerosis and sexual dysfunction. Asian journal of andrology, 2012. 14(4): p. 530.
55. Lamaita, R., et al., Multiple Sclerosis in Pregnancy and its Role in Female Fertility: A Systematic Review. JBRA Assisted Reproduction, 2021. 25(3): p. 493.
56. Imed, M., et al., Sexual Dysfunction during Multiple Sclerosis. Multiple Sclerosis and Related Disorders, 2023. 71: p. 104332.
57. Dastoorpoor, M., et al., Prevalence of sexual dysfunction in men with multiple sclerosis: a systematic review and meta-analysis. Systematic Reviews, 2021. 10(1): p. 1-9.
58. Cavalla, P., et al., Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurological Sciences, 2006. 27(4): p. 231-239.
59. Foster, S.C., et al., Dysregulation of the hypothalamic–pituitary–gonadal axis in experimental autoimmune encephalomyelitis and multiple sclerosis. Journal of neuroimmunology, 2003. 140(1-2): p. 78-87.
60. Safarinejad, M., Evaluation of endocrine profile, hypothalamic–pituitary–testis axis and semen quality in multiple sclerosis. Journal of neuroendocrinology, 2008. 20(12): p. 1368-1375.
61. Marinetto, S., et al., Sexual Dysfunction in Multiple Sclerosis: The Role of Executive Function. Behavioral Sciences, 2023. 13(5): p. 369.